Aurobindo Pharma Limited
AUROPHARMA
Rank in Stocks
#2069
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Share Price
$17.34
Market Cap
$9.98B
Change (1 day)
-3.08%
Change (1 year)
38.71%
Country
IN
Trade Aurobindo Pharma Limited (AUROPHARMA)
Category
Healthcare
Number of shares outstanding for Aurobindo Pharma Limited (AUROPHARMA)
Number of shares outstanding as of June 2026: 578.14M
According to Aurobindo Pharma Limited latest financial reports and stock price the company's current number of shares outstanding is 578.14M. At the end of March 2024 the company had 585.94M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Aurobindo Pharma Limited (AUROPHARMA) from 2004 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 578.14M | -0.81% |
| 2025 | 582.87M | -0.52% |
| 2024 | 585.94M | 0.00% |
| 2023 | 585.94M | -0.01% |
| 2022 | 586.00M | 0.01% |
| 2021 | 585.94M | 0.00% |
| 2020 | 585.94M | 0.01% |
| 2019 | 585.91M | 0.00% |
| 2018 | 585.88M | 0.11% |
| 2017 | 585.22M | 0.16% |
| 2016 | 584.27M | 0.08% |
| 2015 | 583.84M | 0.00% |
| 2014 | 583.84M | 0.23% |
| 2013 | 582.48M | 0.04% |
| 2012 | 582.24M | 1.13% |
| 2011 | 575.74M | 6.32% |
| 2010 | 541.53M | 0.72% |
| 2009 | 537.65M | 0.24% |
| 2008 | 536.39M | 0.63% |
| 2007 | 533.02M | 1.56% |
| 2006 | 524.84M | 3.38% |
| 2005 | 507.70M | 6.06% |
| 2004 | 478.69M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 315.01% |
IN
|
